- £169.67m
- £130.10m
- £6.87m
- 34
- 33
- 52
- 30
Annual balance sheet for Proven Vct, fiscal year end - February 28th, GBP millions except per share, conversion factor applied.
2021 February 28th | 2022 February 28th | 2023 February 28th | 2024 February 29th | 2025 February 28th | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | UAS | UAS | UAS | UAS | UAS |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Cash and Equivalents | |||||
Cash and Short Term Investments | 37 | 23.5 | 46.6 | 44.6 | 39.6 |
Net Total Receivables | 0.065 | 0.343 | 0.499 | 2.5 | 0.933 |
Prepaid Expenses | |||||
Total Current Assets | 37.3 | 24.1 | 47.3 | 47.5 | 40.9 |
Long Term Investments | |||||
Total Assets | 127 | 149 | 163 | 169 | 169 |
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 0.433 | 1.32 | 0.783 | 1.25 | 0.339 |
Total Long Term Debt | |||||
Total Debt | |||||
Total Liabilities | 0.433 | 1.32 | 0.783 | 1.25 | 0.339 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Unrealized Gain / Loss | |||||
Total Equity | 127 | 148 | 162 | 168 | 169 |
Total Liabilities & Shareholders' Equity | 127 | 149 | 163 | 169 | 169 |
Total Common Shares Outstanding |